1. Home
  2. Analysis
  3. Cubicin
  4. Questran

Cubicin and Questran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cubicin (daptomycin) and Questran (cholestyramine). Common drug interactions include diffuse alveolar damage among males.

The phase IV clinical study analyzes what interactions people have when they take Cubicin and Questran. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Cubicin?

Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,991 Cubicin users. Check the latest studies of Cubicin.

What is Questran?

Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.

On Jul, 04, 2026

48 people who take Cubicin and Questran together, and have interactions are studied.

Cubicin and Questran drug interactions.

What are the common drug interactions of Cubicin and Questran, by gender? *:

female:

n/a

male:

  1. Diffuse alveolar damage (common manifestation of drug-induced lung injury)
  2. Dyspnoea (difficult or laboured respiration)
  3. Rectal haemorrhage (bleeding from anus)
  4. Restlessness (not able to rest)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Pulmonary interstitial emphysema syndrome (collection of gases outside of the normal air passages and inside the connective tissue of the peribronchovascular sheaths, interlobular septa, and visceral pleura of lungs)
  8. Death
  9. Rash erythematous (redness of the skin)
  10. Human herpesvirus 6 infection

What are the common drug interactions of Cubicin and Questran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Diffuse alveolar damage (common manifestation of drug-induced lung injury)
  2. Dyspnoea (difficult or laboured respiration)
  3. Rectal haemorrhage (bleeding from anus)
  4. Restlessness (not able to rest)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Pulmonary interstitial emphysema syndrome (collection of gases outside of the normal air passages and inside the connective tissue of the peribronchovascular sheaths, interlobular septa, and visceral pleura of lungs)
  8. Death
  9. Rash erythematous (redness of the skin)
  10. Human herpesvirus 6 infection

What are the existing conditions these people have? *

  1. Skin Infection: 48 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cubicin and Questran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cubicin and Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cubicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cubicin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Questran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on daptomycin and cholestyramine (the active ingredients of Cubicin and Questran, respectively), and Cubicin and Questran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.